Zisková marža spoločnosti Beam Therapeutics
Aká je hodnota metriky Zisková marža spoločnosti Beam Therapeutics?
Hodnota metriky Zisková marža spoločnosti Beam Therapeutics Inc. je -35.09%
Aká je definícia metriky Zisková marža?
Zisková marža (Profit margin) je percento čistého zisku z celkových tržieb.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Zisková marža spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Beam Therapeutics
Čomu sa venuje spoločnosť Beam Therapeutics?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Firmy s metrikou zisková marža podobnou spoločnosti Beam Therapeutics
- Hodnota metriky Zisková marža spoločnosti Raunaq EPC International je -35.31%
- Hodnota metriky Zisková marža spoločnosti Hempstract je -35.31%
- Hodnota metriky Zisková marža spoločnosti Mobecom je -35.25%
- Hodnota metriky Zisková marža spoločnosti China Merchants Commercial Real Estate Investment Trust je -35.23%
- Hodnota metriky Zisková marža spoločnosti Cambium Networks Corp je -35.16%
- Hodnota metriky Zisková marža spoločnosti E-Land Apparel je -35.10%
- Hodnota metriky Zisková marža spoločnosti Beam Therapeutics je -35.09%
- Hodnota metriky Zisková marža spoločnosti Suncity je -35.09%
- Hodnota metriky Zisková marža spoločnosti The Motor & General Finance je -35.06%
- Hodnota metriky Zisková marža spoločnosti Inox Leisure je -35.01%
- Hodnota metriky Zisková marža spoločnosti PopReach je -34.99%
- Hodnota metriky Zisková marža spoločnosti Brooks Laboratories je -34.98%
- Hodnota metriky Zisková marža spoločnosti Paramount Inc je -34.97%